Physiomics (LON:PYC) Stock Jumps 1.7% – Should You Buy?

Shares of Physiomics Plc (LON:PYC – Get Free Report) shot up 1.7% on Thursday. The stock traded as high as GBX 0.42 and last traded at GBX 0.42. Approximately 1,000,000 shares were traded during trading, a decline of 81% from the average session volume of 5,323,432 shares. The stock had previously closed at GBX 0.41.

Physiomics Price Performance

The stock has a market cap of £1.84 million, a price-to-earnings ratio of -2.03 and a beta of 1.05. The company’s fifty day moving average price is GBX 0.47 and its 200-day moving average price is GBX 0.49.

Physiomics (LON:PYC – Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The company reported GBX (0.20) earnings per share for the quarter. Physiomics had a negative net margin of 74.06% and a negative return on equity of 152.03%. On average, sell-side analysts forecast that Physiomics Plc will post -0.13 earnings per share for the current fiscal year.

About Physiomics

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Further Reading

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.